Characterization of Alizarin Red S binding sites and structural changes on human serum albumin: A biophysical study

Journal of Hazardous Materials

Volumn 186, Issue 1, 2011, Pages 352-359

  Ding, Fei ^a   Liu, Wei ^a   Diao, Jian Xiong ^a   Sun, Ying ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Alizarin Red S; Fluorescence spectroscopy; Human serum albumin; Molecular modeling; Protein unfolding

Indexed keywords

ALIZARIN RED; ANTHRAQUINONE DYE; BIOPHYSICAL STUDIES; CIRCULAR DICHROISM; FLUORESCENCE SPECTRA; GUANIDINE HYDROCHLORIDE; HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMINS; HYDROPHOBIC PROBES; MOLECULAR MODELING SIMULATIONS; PROTEIN UNFOLDING; SITE-SPECIFIC; STRUCTURAL CHANGE; STRUCTURAL PERTURBATION; SUBDOMAIN;

BINDING SITES; BIOCHEMISTRY; BODY FLUIDS; DICHROISM; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; KETONES; MOLECULAR MODELING; PROBES;

DYES;

8 ANILINO 1 NAPHTHALENESULFONIC ACID; ALIZARIN RED S; ANTHRAQUINONE; BENZODIAZEPINE; GUANIDINE; HUMAN SERUM ALBUMIN; INDOLE DERIVATIVE;

ABSORPTION; DYE; FLUORESCENCE SPECTROSCOPY; SERUM; ULTRAVIOLET RADIATION; VISIBLE SPECTRUM;

ARTICLE; BINDING SITE; BIOPHYSICS; CIRCULAR DICHROISM; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; HUMAN; HYDROPHOBICITY; LIGHT ABSORPTION; MOLECULAR MODEL; MOLECULAR PROBE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; STOICHIOMETRY; ULTRAVIOLET RADIATION;

ANILINO NAPHTHALENESULFONATES; ANTHRAQUINONES; BINDING SITES; BIOPHYSICS; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN; SPECTRUM ANALYSIS;

EID: 79551535898     PISSN: 03043894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2010.11.002     Document Type: Article

References (38)

1. Jiang Q.G., Ji Y.J., Chang Y.X. Handbook on Toxic Pollutant in Environment Analytical Chemistry 2004, Chemical Industry Press, Beijing. first ed.
2. Brunmark P., Harriman S., Skipper P.L., Wishnok J.S., Amin S., Tannenbaum S.R. Identification of subdomain IB in human serum albumin as a major binding site for polycyclic aromatic hydrocarbon epoxides. Chem. Res. Toxicol. 1997, 10:880-886.
3. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 1992, 358:209-215.
4. Peters T. All About Albumin: Biochemistry, Genetics, Medical Applications, Academic Press 1995, Academic Press, San Diego.
5. Sudlow G., Birkett D.J., Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 1975, 11:824-832.
6. Sengupta A., Hage D.S. Characterization of minor site probes for human serum albumin by high-performance affinity chromatography. Anal. Chem. 1999, 71:3821-3827.
7. de Wolf F.A., Brett G.M. Ligand-binding proteins: their potential for application in systems for controlled delivery and uptake of ligands. Pharmacol. Rev. 2000, 52:207-236.
8. Kamal J.K.A., Zhao L., Zewail A.H. Ultrafast hydration dynamics in protein unfolding: human serum albumin. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:13411-13416.
9. Roche M., Dufour C., Loonis M., Reist M., Carrupt P.-A., Dangles O. Olive phenols efficiently inhibit the oxidation of serum albumin-bound linoleic acid and butyrylcholine esterase. Biochim. Biophys. Acta - General Subjects 2009, 1790:240-248.
10. Bischel H.N., MacManus-Spencer L.A., Luthy R.G. Noncovalent interactions of long-chain perfluoroalkyl acids with serum albumin. Environ. Sci. Technol. 2010, 44:5263-5269.
11. Hebert P.C., MacManus-Spencer L.A. Development of a fluorescence model for the binding of medium- to long-chain perfluoroalkyl acids to human serum albumin through a mechanistic evaluation of spectroscopic evidence. Anal. Chem. 2010, 82:6463-6471.
12. MacManus-Spencer L.A., Tse M.L., Hebert P.C., Bischel H.N., Luthy R.G. Binding of perfluorocarboxylates to serum albumin: a comparison of analytical methods. Anal. Chem. 2010, 82:974-981.
13. Monti S., Manet I., Manoli F., Marconi G. Structure and properties of licochalcone A-human serum albumin complexes in solution: a spectroscopic, photophysical and computational approach to understand drug-protein interaction. Phys. Chem. Chem. Phys. 2008, 10:6597-6606.
14. Sudlow G., Birkett D.J., Wade D.N. Spectroscopic techniques in the study of protein binding: the use of 1-anilino-8-naphthalenesulphonate as a fluorescent probe for the study of the binding of iophenoxic and iopanoic acids to human serum albumin. Mol. Pharmacol. 1973, 9:649-657.
15. Lakowicz J.R. Principles of Fluorescence Spectroscopy 2006, Springer Science+Business Media, New York. third ed.
16. Jain A.N., Surflex: Fully automatic flexible molecular docking using a molecular similarity-based search engine. J. Med. Chem. 2003, 46:499-511.
17. Greenfield N.J., Fasman G.D. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 1969, 8:4108-4116.
18. Abou-Zied O.K., Al-Shihi O.I.K. Characterization of subdomain IIA binding site of human serum albumin in its native, unfolded, and refolded states using small molecular probes. J Am. Chem. Soc. 2008, 130:10793-10801.
19. Gentili P.L., Ortica F., Favaro G. Static and dynamic interaction of a naturally occurring photochromic molecule with bovine serum albumin studied by UV-visible absorption and fluorescence spectroscopy. J. Phys. Chem. 2008, B 112:16793-16801.
20. Divsalar A., Bagheri M.J., Saboury A.A., Mansoori-Torshizi H., Amani M. Investigation on the interaction of newly designed anticancer Pd(II) complexes with different aliphatic tails and human serum albumin. J. Phys. Chem. B 2009, 113:14035-14042.
21. Banerjee T., Singh S.K., Kishore N. Binding of naproxen and amitriptyline to bovine serum albumin: biophysical aspects. J. Phys. Chem. 2006, B 110:24147-24156.
22. Balbinot D., Atalick S., Guldi D.M., Hatzimarinaki M., Hirsch A., Jux N. Electrostatic assemblies of fullerene-porphyrin hybrids: toward long-lived charge separation. J. Phys. Chem. 2003, B 107:13273-13279.
23. Ahmad B., Ahmed M.Z., Haq S.K., Khan R.H. Guanidine hydrochloride denaturation of human serum albumin originates by local unfolding of some stable loops in domain III. Biochim. Biophys. Acta - Proteins & Proteomics 2005, 1750:93-102.
24. Galantini L., Leggio C., Pavel N.V. Human serum albumin unfolding: A small-angle X-ray scattering and light scattering study. J. Phys. Chem. B 2008, 112:15460-15469.
25. Stryer L. Fluorescence spectroscopy of proteins. Science 1968, 162:526-533.
26. Weber G., Daniel E. Cooperative effects in binding by bovine serum albumin. II. The binding of 1-anilino-8-naphthalenesulfonate. Polarization of the ligand fluorescence and quenching of the protein fluorescence. Biochemistry 1966, 5:1900-1907.
27. Stryer L. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin: a fluorescent probe of non-polar binding sites. J. Mol. Biol. 1965, 13:482-495.
28. Bagatolli L.A., Kivatinitz S.C., Aguilar F., Soto M.A., Sotomayor P., Fidelio G.D. Two distinguishable fluorescent modes of 1-anilino-8-naphthalenesulfonate bound to human albumin. J. Fluoresc. 1996, 6:33-40.
29. Cattoni D.I., Kaufman S.B., Flecha F.L.G. Kinetics and thermodynamics of the interaction of 1-anilino-naphthalene-8-sulfonate with proteins. Biochim. Biophys. Acta - Proteins & Proteomics 2009, 1794:1700-1708.
30. Hawe A., Poole R., Jiskoot W. Misconceptions over Förster resonance energy transfer between proteins and ANS/bis-ANS: direct excitation dominates dye fluorescence. Anal. Biochem. 2010, 401:99-106.
31. Carter D.C., Ho J.X. Structure of serum albumin. Adv. Protein Chem. 1994, 45:153-203.
32. Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., Curry S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 2005, 353:38-52.
33. Sjöholm I., Ekman B., Kober A., Ljungstedt-Påhlman I., Seiving B., Sjödin T. Binding of drugs to human serum albumin:XI.1 The specificity of three binding sites as studied with albumin immobilized in microparticles2. Mol. Pharmacol. 1979, 16:767-777.
34. Russo D., Ollivier J., Teixeira J. Water hydrogen bond analysis on hydrophilic and hydrophobic biomolecule sites. Phys. Chem. Chem. Phys. 2008, 10:4968-4974.
35. Sułkowska A. Interaction of drugs with bovine and human serum albumin. J. Mol. Struct. 2002, 614:227-232.
36. Greenfield N.J. Determination of the folding of proteins as a function of denaturants, osmolytes or ligands using circular dichroism. Nat. Protoc. 2006, 1:2733-2741.
37. Mandeville J.S, Tajmir-Riahi H.-A. Complexes of dendrimers with bovine serum albumin. Biomacromolecules 2010, 11:465-472.
38. Charbonneau D.M., Tajmir-Riahi H.-A. Study on the interaction of cationic lipids with bovine serum albumin. J. Phys. Chem. 2010, B 114:1148-1155.